| Tiotropium (Spiriva): a once-daily inhaled anticholinergic medication for chronic obstructive pulmonary disease. | |
| | |
MedLine Citation:
|
PMID: 16200123 Owner: NLM Status: PubMed-not-MEDLINE |
Abstract/OtherAbstract:
|
Tiotropium represents a new generation of inhaled therapy. No other inhaled product has demonstrated effectiveness with once-daily dosing. Treatment has been associated with improved lung function, decrease in the number of exacerbations, increase in the time to first exacerbation, and improved quality of life. Adverse effects appear to be mild in nature, and the only significant adverse effect is dry mouth. Clinical trials show that tiotropium is more effective than placebo. When compared with current treatment for chronic obstructive pulmonary disease, tiotropium is at least as effective as salmeterol and more effective than ipratropium; moreover, the once-a-day dosing increases the likelihood of patient compliance. The guidelines of the Global Initiative for Chronic Obstructive Lung Disease recommend bronchodilator medications as first-line therapy in the symptomatic management of chronic obstructive pulmonary disease. Tiotropium, an anticholinergic bronchodilator, should be considered a first-line agent for patients with chronic obstructive pulmonary disease. |
| | |
Authors:
|
Martha C Durham |
Related Documents
:
|
9363103 - Pulmonary langerhans cell granulomatosis. 15370743 - Identification of relevant icf categories in patients with chronic health conditions: a... 2616823 - Respiratory impairment in inflammatory bowel disease: does it vary with disease activity? |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Proceedings (Baylor University. Medical Center) Volume: 17 ISSN: 0899-8280 ISO Abbreviation: Proc (Bayl Univ Med Cent) Publication Date: 2004 Jul |
Date Detail:
|
Created Date: 2005-10-03 Completed Date: 2005-10-20 Revised Date: 2009-11-18 |
Medline Journal Info:
|
Nlm Unique ID: 9302033 Medline TA: Proc (Bayl Univ Med Cent) Country: United States |
Other Details:
|
Languages: eng Pagination: 366-73 Citation Subset: - |
Affiliation:
|
Department of Pharmacy Services, Baylor University Medical Center, Dallas, Texas 75246, USA. marthadu@baylorhealth.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: A baseline study of medication error rates at Baylor University Medical Center in preparation for im...
Next Document: Clinical and necropsy findings in patients with calcified myocardial infarcts.